Literature DB >> 3108932

Oral tyramine pressor test and the safety of MAO inhibitor drugs.

R Schulz, P R Bieck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108932     DOI: 10.1007/bf00216021

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  2 in total

1.  Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.

Authors:  A Korn; H G Eichler; R Fischbach; S Gasic
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Tyramine studies and the safety of MAOI drugs.

Authors:  G M Simpson; K White
Journal:  J Clin Psychiatry       Date:  1984-07       Impact factor: 4.384

  2 in total
  4 in total

1.  Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).

Authors:  Andrea F D Di Stefano; Milko Massimiliano Radicioni; Antonio Rusca
Journal:  Neurotox Res       Date:  2012-08-08       Impact factor: 3.911

2.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

3.  Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.

Authors:  C Audebert; O Blin; S Monjanel-Mouterde; P Auquier; A M Pedarriosse; J Dingemanse; A Durand; J P Cano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

Authors:  N P Nair; S K Ahmed; N M Kin
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.